Clostridium difficile infection: a review of current and emerging therapies
about
Bacterial Communities: Interactions to ScaleClostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model.Nonantimicrobial drug targets for Clostridium difficile infections.Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.Genome characterization of a novel binary toxin-positive strain of Clostridium difficile and comparison with the epidemic 027 and 078 strains.Next-generation probiotics targeting Clostridium difficile through precursor-directed antimicrobial biosynthesis.Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.CRISPR Diversity and Microevolution in Clostridium difficile.Clostridium difficile infection in the elderly: an update on management.Routine Treatment-Resistant Clostridium difficile Infection during Recovery from Myxedema.Impact of oral fidaxomicin administration on the intestinal microbiota and susceptibility to Clostridium difficile colonization in mice.Genome-Based Comparison of Clostridioides difficile: Average Amino Acid Identity Analysis of Core Genomes.Advances in the diagnosis and treatment of Clostridium difficile infections.Treatment of recurrent Clostridium difficile colitis: a narrative review.A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment.Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Genome-Wide Typing of Clostridium difficile.Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.Bezlotoxumab.
P2860
Q26739810-8D03B28F-FB14-4683-841F-3D72F13669BDQ33561562-09C3F879-08AD-4173-9B60-311627998C46Q33586133-A7AF5AF8-03A5-465A-9109-A4329188FAD6Q38649348-C1729F51-A0BB-41D8-BD97-1DFD9AB5EA8AQ39238893-62ABB4B5-7836-4AB8-B1D0-FFC3CC614294Q40065343-FEF1D99F-41BA-4CA3-82E9-E9EA3CFBBE5FQ40099512-A9BDB050-D52F-4189-882C-4A1F8D7B456DQ40100634-3A5EE0B8-B1B8-488F-B1A0-B15D852285CDQ40110130-B8071408-2D73-4618-8696-0EBD967704E8Q40408569-56A2804E-2BAD-4CAE-8345-55EB2BA4EFDFQ40557862-486D7798-14D5-483A-AC82-47B8BB9E4987Q47142602-D8C4E39F-E3DF-4F7D-AE9C-305F80A70558Q49770397-DF8D8F18-5742-4317-A627-4B49A6006169Q49792028-F4A0B463-10C1-4954-A9F6-1FD3670D060EQ49994322-FDDA5C3E-15C4-4C0C-8290-ABC0552BEE38Q50055623-8F9308EA-E5D7-4380-B897-914016968EB7Q50285268-1CDE81AC-8D0B-4A80-BBB6-9DF46E08E793Q50608427-261C777B-827E-4490-8ECE-C626D89F17BEQ52606593-CB892228-4EDB-45BC-AD09-4457852B3D06Q53692769-891C8011-E86F-4030-9BAB-EC931FC3DD68Q53762105-04231206-BA1A-4A9A-AD79-B135A37A5AC9
P2860
Clostridium difficile infection: a review of current and emerging therapies
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Clostridium difficile infection: a review of current and emerging therapies
@ast
Clostridium difficile infection: a review of current and emerging therapies
@en
Clostridium difficile infection: a review of current and emerging therapies
@nl
type
label
Clostridium difficile infection: a review of current and emerging therapies
@ast
Clostridium difficile infection: a review of current and emerging therapies
@en
Clostridium difficile infection: a review of current and emerging therapies
@nl
prefLabel
Clostridium difficile infection: a review of current and emerging therapies
@ast
Clostridium difficile infection: a review of current and emerging therapies
@en
Clostridium difficile infection: a review of current and emerging therapies
@nl
P2860
P3181
P356
P1476
Clostridium difficile infection: a review of current and emerging therapies
@en
P2093
Andrew Ofosu
P2860
P304
P3181
P356
10.20524/AOG.2016.0006
P407
P577
2016-01-01T00:00:00Z